The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.625
Bid: 0.55
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.15 (27.273%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.625
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Provexis Inks Agreement For Fruitflow+ Omega-3 Distributor In China

Mon, 16th Nov 2020 11:26

(Alliance News) - Shares in Provexis PLC surged on Monday after it said it signed a deal with a company which will act as the distributor in China for heart-health food ingredient Fruitflow+ Omega-3.

The food technology company stated the agreement gives the unnamed distributor the exclusive rights to import, market and sell the Fruitflow+ Omega-3 dietary supplement product in China through the Chinese Cross-Border e-commerce channel.

Provexis highlighted a steady growth of subscriber numbers on its website.

Shares in Provexis were trading 40% higher at 1.05 pence each late Monday morning in London. They rose as high as 1.48p earlier, a new 52-week high.

By Ife Taiwo; ifetaiwo@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Dec 2009 08:49

Small caps round-up: Landore Resources, TXO, Aortech...

Shares in Landore Resources jumped after the Canadian miner said it made a 'significant gold discovery' in its Junior Lake property in the province of Ontario. Shares in Texas-focused oil and gas firm TXO slumped after it said oil production in the six months to September 30 fell to 13,221 barrels

Read more
3 Nov 2009 12:16

Small cap round-up: Provexis, Puricore, Sirius, Sopheon, Spiritel

Food technology group Provexis says it has been told that the European Commission review into the health claim wording for its Fruitflow anti-thrombatic technology for use on consumer products is now in "an advanced stage". Puricore's third quarter sales rose 25% to $10.8m, with the nine month tot

Read more
11 Aug 2009 09:30

Provexis surges on Crohn's disease trial

Provexis, the life-science business, has begun a clinical trial for its NSP#3G plantain medical food for Crohn's disease patients. "With the trial now starting and combined with recently obtained healthy human data, the Company will now commence seeking to identify potential global license or co-de

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.